Calvert Formula, Mawer (m)

GFR Mawer

The Calvert formula calculates carboplatin dose by targeting a specific AUC using measured or estimated GFR to individualize exposure 1.

mg/dLumol/L
kglbs
yrs
mg/ml*min

Indications for Use

Used to individualize carboplatin dosing by targeting a precise AUC based on measured/accurately estimated GFR, improving exposure prediction and minimizing under‑ or overdosing. Primary use is in platinum‑based chemotherapy where renal function determines clearance. Clinical utility: ensures predictable AUC (Calvert prospective validation n=31; r=0.886) 1, avoids GFR‑estimate–related misdosing (eGFRcr‑cys reduces overdose risk 3–4× vs eGFRcr) 2.

Insights & Cautions

Use measured or cystatin‑C–creatinine eGFR when possible to avoid misdosing. Creatinine‑based estimates alone can misestimate GFR in cancer, risking carboplatin over‑ or under‑exposure 1 [Level II evidence]. CG overestimates clearance, especially with enzymatic creatinine, causing overdosing; adding 0.2 mg/dL corrects this 2 [Level II evidence]. Mawer‑type formulas still depend on accurate creatinine, so errors propagate. Measured GFR remains most reliable for narrow‑therapeutic‑index dosing 3 [Level I evidence].